Clinical Trial Update: A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing CDR132L with placebo to assess effects on heart structure and function in people with heart failure with reduced or mildly redu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Hypertrophy

Drugs mentioned

• CDR132L

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Heart Failure | Phase 2 | Status: RECRUITING